Process and formulation development

Nordmark Pharma GmbH provides a wide range of biological APIs which include pancreatin powder produced in Germany. It is differentiated by excellent free-flow properties and a high bulk density. The material can be used for direct compression tablet formulations. Diverse pancreatin powder product quali...

Nordmark Pharma GmbH provides a wide range of products based on our own produced biological APIs produced in Germany, which include enteric coated pancreatin pellets with high specific enzymatic activity and therefore patient-friendly capsule sizes. Diverse pellet product qualities according to custome...

Nordmark Pharma GmbH provides a wide range of drug products based on our own biological APIs produced in Germany, which include enteric-coated pancreatin micro tablets. Contrary to pellets, micro tablets are uniform in shape and the amount of active pharmaceutical ingredient of each tablet is exactly defin...

Apart from biological APIs Nordmark Pharma GmbH provides Collagenase NB derived from Clostridium histolyticum. Collagenase NB is a chromatographically purified mixture of enzymes used for tissue dissociation in-vitro and thus applicable for isolation of many different types of cells. The isolated cells ...

Apart from biological APIs Nordmark Pharma GmbH provides Collagenase AF derived from Clostridium histolyticum using an animal free (AF) cultivation media. Collagenase AF is a chromatographically purified mixture of enzymes used for tissue dissociation in-vitro and thus applicable for isolation of many ...

Nordmark Arzneimittel GmbH & Co. KG provides a wide range of biological APIs, including Collagenase N powder. Our collagenase is an enzyme preparation produced by fermentation using Clostridium histolyticum followed by purification and subsequent aseptic lyophilisation. At Nordmark, this asep...

Nordmark Arzneimittel GmbH & Co. KG provides a wide range of services, including the manufacture of investigational medicinal products (IMP), in particular based on biological APIs. Capability to produce microbiom IMP under anaerobic conditions. Contact us for more information.

Nordmark Arzneimittel GmbH & Co. KG provides a wide range of biotech services such as strain (including MCB and WCB Production) and process development - including special experience in microbiom formulation - up to clinical phase III. Contact us for more information.

Nordmark Arzneimittel GmbH & Co. KG provides finished drug products for the treatment of the gastrointestinal system, produced in Germany from our own API and designated for GI-treatment. This includes the brand Pankreatan® and Pankreatin 40.000 Nordmark®, pankreatin containing enteric coated micro ...

Nordmark Arzneimittel GmbH & Co. KG provides a wide range of biological drug products made from our own APIs produced in Germany. This includes Thrombophob® 60.000, a heparin ointment with 2 alternative ointment bases: a) gel b) creamogel. Contact us for more information.

Burlulipase is a pure, liquid, animal- and virus-free, highly active, and acid-stable lipase-only product from bacterial fermentation. This enzyme is tested in clinical trials with patients suffering from the failure or impairment of the pancreatic digestive function (exocrine pancreatic insufficiency, ...

Nordmark Biotech bundles all biotechnological activities ofNordmark. We are offering an all-in-one solution for microbialfermentation based products covering the entire value chain fromprocess development, analytics, production of API and finisheddrug product up to regulatory affairs and marketing authorisation.Our worldwide customers benefit from this integrated approach,which is based on solid project management, long-standing GMPexperience and recurrent EMA and FDA approvals.